Latest Insider Transactions at Everest Re Group LTD (RE)
This section provides a real-time view of insider transactions for Everest Re Group LTD (RE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of EVEREST RE GROUP LTD to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of EVEREST RE GROUP LTD's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 26
2025
|
James Allan Williamson CEO |
BUY
Grant, award, or other acquisition
|
Direct |
11,105
+20.42%
|
$3,820,120
$344.48 P/Share
|
|
Feb 26
2025
|
Ricardo Anzaldua Executive VP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
1,580
+28.48%
|
$543,520
$344.48 P/Share
|
|
Feb 26
2025
|
Mark Kociancic EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
7,258
+9.87%
|
$2,496,752
$344.48 P/Share
|
|
Feb 26
2025
|
Robert J Freiling SVP&Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
944
+12.4%
|
$324,736
$344.48 P/Share
|
|
Feb 26
2025
|
Robert J Freiling SVP&Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
50
-0.87%
|
$17,200
$344.48 P/Share
|
|
Feb 26
2025
|
Gail Van Beveren EVP and Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
108
-0.81%
|
$37,152
$344.48 P/Share
|
|
Feb 26
2025
|
Mike Karmilowicz EVP, Chairman Insurance |
SELL
Payment of exercise price or tax liability
|
Direct |
122
-1.01%
|
$41,968
$344.48 P/Share
|
|
Feb 24
2025
|
Mike Karmilowicz EVP, Chairman Insurance |
SELL
Payment of exercise price or tax liability
|
Direct |
611
-1.63%
|
$207,740
$340.4 P/Share
|
|
Feb 24
2025
|
Gail Van Beveren EVP and Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
435
-1.06%
|
$147,900
$340.4 P/Share
|
|
Feb 24
2025
|
Joseph V Taranto Director |
SELL
Payment of exercise price or tax liability
|
Direct |
287
-0.05%
|
$97,580
$340.4 P/Share
|
|
Feb 24
2025
|
James Allan Williamson CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
810
-1.92%
|
$275,400
$340.4 P/Share
|
|
Feb 24
2025
|
Robert J Freiling SVP&Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
181
-1.02%
|
$61,540
$340.4 P/Share
|
|
Jan 02
2025
|
Meryl D Hartzband Director |
BUY
Grant, award, or other acquisition
|
Direct |
86
+0.84%
|
$31,218
$363.27 P/Share
|
|
Nov 18
2024
|
Mark Kociancic EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,149
-7.2%
|
$795,130
$370.08 P/Share
|
|
Nov 18
2024
|
James Allan Williamson CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
646
-4.3%
|
$239,020
$370.08 P/Share
|
|
Nov 14
2024
|
James Allan Williamson CEO |
SELL
Open market or private sale
|
Direct |
200
-1.32%
|
$74,000
$370.0 P/Share
|
|
Nov 04
2024
|
William F Galtney Jr Director |
BUY
Open market or private purchase
|
Direct |
2,870
+8.04%
|
$998,760
$348.64 P/Share
|
|
Nov 04
2024
|
Mike Karmilowicz EVP, Chairman Insurance |
SELL
Open market or private sale
|
Direct |
269
-2.07%
|
$93,612
$348.48 P/Share
|
|
Oct 01
2024
|
Meryl D Hartzband Director |
BUY
Grant, award, or other acquisition
|
Direct |
79
+0.78%
|
$30,968
$392.99 P/Share
|
|
Sep 18
2024
|
Juan C Andrade President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,927
-6.39%
|
$1,527,603
$389.47 P/Share
|
|
Jul 01
2024
|
Meryl D Hartzband Director |
BUY
Grant, award, or other acquisition
|
Direct |
81
+0.8%
|
$30,861
$381.34 P/Share
|
|
May 09
2024
|
Geraldine Losquadro Director |
SELL
Open market or private sale
|
Direct |
1,000
-7.22%
|
$380,000
$380.49 P/Share
|
|
Apr 01
2024
|
Meryl D Hartzband Director |
BUY
Grant, award, or other acquisition
|
Direct |
78
+0.78%
|
$30,966
$397.38 P/Share
|
|
Mar 14
2024
|
Juan C Andrade President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,733
-7.15%
|
$1,826,938
$386.65 P/Share
|
|
Mar 14
2024
|
Juan C Andrade President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,252
+12.26%
|
$3,571,272
$386.65 P/Share
|
|
Mar 14
2024
|
Mark Kociancic EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,173
-3.78%
|
$452,778
$386.65 P/Share
|
|
Mar 14
2024
|
Mark Kociancic EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,293
+6.88%
|
$885,098
$386.65 P/Share
|
|
Mar 14
2024
|
Mike Karmilowicz EVP, Chairman Insurance |
SELL
Payment of exercise price or tax liability
|
Direct |
777
-5.64%
|
$299,922
$386.65 P/Share
|
|
Mar 14
2024
|
Mike Karmilowicz EVP, Chairman Insurance |
BUY
Grant, award, or other acquisition
|
Direct |
1,521
+9.95%
|
$587,106
$386.65 P/Share
|
|
Mar 14
2024
|
James Allan Williamson CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
872
-5.42%
|
$336,592
$386.65 P/Share
|
|
Mar 14
2024
|
James Allan Williamson CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,609
+9.1%
|
$621,074
$386.65 P/Share
|
|
Feb 29
2024
|
Hazel Mc Neilage Director |
BUY
Grant, award, or other acquisition
|
Direct |
888
+28.16%
|
$325,896
$367.04 P/Share
|
|
Feb 29
2024
|
William F Galtney Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
888
+2.88%
|
$325,896
$367.04 P/Share
|
|
Feb 29
2024
|
John J Amore Director |
BUY
Grant, award, or other acquisition
|
Direct |
888
+3.69%
|
$325,896
$367.04 P/Share
|
|
Feb 29
2024
|
Meryl D Hartzband Director |
BUY
Grant, award, or other acquisition
|
Direct |
888
+8.28%
|
$325,896
$367.04 P/Share
|
|
Feb 29
2024
|
John A Graf Director |
BUY
Grant, award, or other acquisition
|
Direct |
888
+5.37%
|
$325,896
$367.04 P/Share
|
|
Feb 29
2024
|
Joseph V Taranto Director |
BUY
Grant, award, or other acquisition
|
Direct |
888
+0.3%
|
$325,896
$367.04 P/Share
|
|
Feb 29
2024
|
Roger M. Singer Director |
BUY
Grant, award, or other acquisition
|
Direct |
888
+4.75%
|
$325,896
$367.04 P/Share
|
|
Feb 29
2024
|
Geraldine Losquadro Director |
BUY
Grant, award, or other acquisition
|
Direct |
888
+6.03%
|
$325,896
$367.04 P/Share
|
|
Feb 28
2024
|
Robert J Freiling SVP&Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
880
+12.87%
|
$324,720
$369.52 P/Share
|
|
Feb 28
2024
|
James Allan Williamson CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,627
+20.04%
|
$1,338,363
$369.52 P/Share
|
|
Feb 28
2024
|
Mark Kociancic EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
3,708
+11.43%
|
$1,368,252
$369.52 P/Share
|
|
Feb 28
2024
|
Mike Karmilowicz EVP, Chairman Insurance |
BUY
Grant, award, or other acquisition
|
Direct |
2,539
+17.17%
|
$936,891
$369.52 P/Share
|
|
Feb 28
2024
|
Juan C Andrade President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
8,119
+12.48%
|
$2,995,911
$369.52 P/Share
|
|
Feb 27
2024
|
Mike Karmilowicz EVP, Chairman Insurance |
SELL
Payment of exercise price or tax liability
|
Direct |
141
-1.43%
|
$51,465
$365.68 P/Share
|
|
Feb 27
2024
|
Robert J Freiling SVP&Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
62
-1.21%
|
$22,630
$365.68 P/Share
|
|
Feb 26
2024
|
Robert J Freiling SVP&Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
50
-0.96%
|
$18,500
$370.06 P/Share
|
|
Feb 26
2024
|
Juan C Andrade President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
693
-1.4%
|
$256,410
$370.06 P/Share
|
|
Feb 26
2024
|
Mike Karmilowicz EVP, Chairman Insurance |
SELL
Payment of exercise price or tax liability
|
Direct |
122
-1.22%
|
$45,140
$370.06 P/Share
|
|
Feb 24
2024
|
Joseph V Taranto Director |
SELL
Payment of exercise price or tax liability
|
Direct |
200
-0.03%
|
$74,000
$370.06 P/Share
|